Search filters

List of works by Miriam A Hobbs

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

scientific article published on 25 February 2020

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

scientific article published on 01 August 2020

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

scientific article published on 18 September 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.

scientific article published on 15 February 2018

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 29 July 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

scientific article published on 11 December 2020

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

scientific article published on 11 August 2020

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

scientific article published on 14 August 2017

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

scientific article published on 20 February 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

scientific article published on 16 May 2019

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

scientific article published on 25 October 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

scientific article published on 11 August 2017

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

scientific article published on 08 January 2020

Impact of acquired del(17p) in multiple myeloma

scientific article published on 01 July 2019

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

scientific article published on 27 September 2017

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

scientific article published on 21 December 2017

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

scientific article published on 02 October 2020

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

scientific article published on 08 January 2020

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

scientific article published on 01 May 2020

Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic

scientific article published on 01 May 2020

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

scientific article

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

scientific article published on 12 March 2019

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

scientific article published on 08 February 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

scientific article published on 21 February 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

scientific article published on 30 April 2019

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

scientific article published on 18 July 2020

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

scientific article published on 15 October 2018

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

scientific article

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

scientific article published on 16 April 2018

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

scientific article published on 01 December 2020

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

scientific article published on 02 October 2018

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

scientific article published on 02 October 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

scientific article

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

scientific article published on 04 March 2020

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Paulina is supported by:

About Paulina

Help